-transparent.png){kind=logo}
Specific high-affinity binding of 3H-imipramine to human platelets possesses very similar characteristics to the sites previously described in animal and human brains. In a study comparing the binding of 3H-imipramine in platelets obtained from 39 control volunteers with 37 hospitalized, untreated, severely depressed patients, the maximal binding of 3H-imipramine was found to be significantly lower in the depressed population. There were no differences in the KD values. After 7-15 days of treatment with tricyclic anti-depressant drugs, there was an improvement in the degree of the depression but no significant change in the maximal 3H-imipramine binding. After an average of 50 days treatment, Hamilton ratings had returned to normal, but the 3H-imipramine binding values remained unchanged.
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
October 1985,
Psychiatry research,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
October 1979,
European journal of pharmacology,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
January 1984,
Neuropsychobiology,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
January 1999,
Journal of affective disorders,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
January 1985,
Psychiatry research,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
December 1982,
FEBS letters,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
October 1982,
Psychiatry research,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
June 1997,
Journal of affective disorders,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
March 1986,
Life sciences,
R Raisman, and
D Sechter, and
M S Briley, and
E Zarifian, and
S Z Langer
January 1982,
Advances in biochemical psychopharmacology,
